Next-Generation Biotech Innovations
Mission
At SunVax, our mission is to advance human health worldwide through cutting-edge mRNA biotechnology. We are committed to pioneering innovative therapies that address the most critical and unmet medical challenges of our time.
Team
Our team of scientists and researchers are recognized leaders in biotechnology with deep expertise in developing next-generation mRNA therapeutics. We continuously pursue novel approach to enhance patient outcomes and therapeutic efficacy.
Partnership
We offer a range of strategic partnership opportunities, potential therapeutics with targeted applications, research use CTSD™ (cell type specific delivery) and TSD™ (tissue specific delivery) kits for our community to advance mRNA medicines. Our proprietary LNPs enable precise, cell-targeted drug delivery, unlocking the promise of precision medicine and beyond.
Introduction
SunVax mRNA Therapeutics is a biotechnology company pioneering next-generation mRNA medicines through proprietary lipid nanoparticle (LNP) platforms and self-amplifying mRNA (samRNA) technologies. SunVax’s strategic focus is to harness these platforms to address critical unmet needs in oncology, infectious diseases, and autoimmune disorders. By engineering smarter delivery systems and more powerful payloads, we aim to overcome key barriers in mRNA medicine—achieving enhanced efficacy, safety, and scalability.